A case control study of sarcosine as an early prostate cancer detection biomarker

BACKGROUND: Sarcosine has been investigated as a prostate cancer biomarker with mixed results concerning its predictive power. We performed a case–control evaluation of the predictive value of serum sarcosine for early detection in a population-based cohort of men undergoing prostate-specific antige...

Descripción completa

Detalles Bibliográficos
Autores principales: Ankerst, Donna P., Liss, Michael, Zapata, David, Hoefler, Josef, Thompson, Ian M., Leach, Robin J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4591628/
https://www.ncbi.nlm.nih.gov/pubmed/26429735
http://dx.doi.org/10.1186/s12894-015-0095-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4591628/
https://www.ncbi.nlm.nih.gov/pubmed/26429735
http://dx.doi.org/10.1186/s12894-015-0095-5

Ejemplares similares